Baxter International Tagged Articles
MIT report proves type of contaminant in Chinese heparin
A team of researchers from the Massachusetts Institute of Technology (MIT) has confirmed that over-sulfated chondroitin sulfate was, in fact, the contaminant in heparin that was manufactured in China and triggered serious allergic reactions that caused more than 80 Americans to
Baxter International spent thousands on lobbying efforts
Drug maker Baxter International Inc., shelled out more than $720,000 in the third quarter of the year lobbying on health care issues including government reimbursement for kidney dialysis treatment and increased funding for kidney disease education, according to Forbes/Associated Press.
Scientists on road to modifying, customizing human heparin
Scientists at University of North Carolina at Chapel Hill have learned to modify the human enzyme that produces heparin, which may lead to a more effective synthetic version of the blood thinner, according to Newswise Medical News.
Time shares story of family affected by heparin contamination
A recent Time magazine story gives us a glimpse into a family affected by the contaminated heparin tragedy: Leroy Hubley’s wife of 48 years, Bonnie, suffered from polycystic kidney disease, a genetic kidney disease in which cysts grow in the
Contaminated heparin removed from Cinnicinnati plant
The U.S. Food and Drug Administration (FDA) issued and FDA NEWS release today informing the public that it has removed 11 lots of heparin from Celsus Laboratories, Inc., in Cinncinnati, Ohio. According to the release, the FDA has determined five
Heparin used in innovative cholesterol-separating method
People who have high cholesterol may have another alternative to statin drugs – a method that literally sucks bad cholesterol right out of a patient’s blood, according to the St. Louis Post-Dispatch.
FDA will not name Chinese plants that supplied tainted heparin
The U.S. Food and Drug Administration (FDA) is at odds with congressional investigators over an investigation into the federal agency’s inspection of foreign drug manufacturing facilities.
Despite recall, Baxter International enjoys third-quarter gains
Despite heparin-recall woes earlier in the year, Pharmaceutical drug giant Baxter International announced that it had a 19 percent increase in third-quarter profits, according to a Baxter International press release.
Pharmaceutical companies developing drugs to fight blood clots
Five pharmaceutical companies are working on new medications to treat blood clots, also known as thrombosis, according to The Wall Street Journal. Thrombosis is a serious problem affecting nearly 900,000 Americans each year, and resulting in nearly 300,00 deaths annually.
